Cyclacel Pharmaceuticals Preferred Stock Today
| CYCCP Preferred Stock | USD 6.16 0.55 8.20% |
PerformanceInsignificant
| Odds Of DistressAverage
|
Cyclacel Pharmaceuticals is selling at 6.16 as of the 23rd of March 2025; that is 8.2 percent decrease since the beginning of the trading day. The preferred stock's last reported lowest price was 6.16. Cyclacel Pharmaceuticals has 54 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey. Cyclacel Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.. The company has 12.5 M outstanding shares. More on Cyclacel Pharmaceuticals
Moving against Cyclacel Preferred Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cyclacel Preferred Stock Highlights
| CEO | Spiro Rombotis |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Cyclacel Pharmaceuticals (CYCCP) is traded on NASDAQ Exchange in USA. It is located in 200 Connell Drive, Berkeley Heights, NJ, United States, 07922 and employs 14 people. Cyclacel Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cyclacel Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Cyclacel Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cyclacel Pharmaceuticals classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 12.5 M outstanding shares.
Cyclacel Pharmaceuticals has accumulated about 29.08 M in cash with (18.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.32.
Check Cyclacel Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Cyclacel Pharmaceuticals is $23.14 Million. Almost 99.53 percent of Cyclacel Pharmaceuticals outstanding shares are held by general public with 0.47 (percent) owned by insiders and only 0.0 % by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Cyclacel Ownership Details
Cyclacel Pharmaceuticals Risk Profiles
| Risk Adjusted Performance | 0.0359 | |||
| Jensen Alpha | 0.3105 | |||
| Total Risk Alpha | 1.03 | |||
| Sortino Ratio | 0.0338 |
Cyclacel Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cyclacel Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Additional Tools for Cyclacel Preferred Stock Analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.